Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Approval
|
Mid-range Performer
348.3500
-4.90
(
-1.39
%)
NSE
Aug 29, 2025
15:31 PM
Volume:
1.8M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
12 Nov 2023
US FDA Approval
348.35
-1.39%
Delay in new approvals drags biosimilar prospects
Neutral:
Biocon Ltd.
by
Motilal Oswal
Target: 220
Target
Motilal Oswal
Biocon Ltd. is trading below all available SMAs
More from Biocon Ltd.
Recommended
Five Interesting Stocks Today - August 29, 2025
The Baseline |
29 Aug 2025, 05:09PM
Market closes lower, Reliance Jio Infocomm to list by first half of 2026
Trendlyne Marketwatch |
29 Aug 2025, 03:59PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020